Boothbay Fund Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Boothbay Fund Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,684	Closed	-$107K	–	2383
2021 Q3	$107K	Sell	10,684 -20,941	-66%	-$210K	﹤0.01%	1786
2021 Q2	$318K	Buy	31,625 +4,115	+15%	+$41.7K	0.01%	1240
2021 Q1	$280K	Buy	27,510 +13,141	+91%	+$140K	0.01%	1225
2020 Q4	$149K	Buy	+14,369	New	+$150K	0.01%	1131

Other funds holding FLACU

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Boothbay Fund Management's FLACU Position: Q4 2021 in Review

Boothbay Fund Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2021, closing a stake of 10,684 shares — an estimated $107K sold.

Boothbay Fund Management first reported a position in FLACU in Q4 2020 and held it in 4 quarters. The position peaked at $318K in Q2 2021. 23 funds tracked by Wall St. Rank hold FLACU as of Q4 2021.

Boothbay Fund Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2021 after selling out during the quarter.
Boothbay Fund Management sold 10,684 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2021, an estimated $107K.
Boothbay Fund Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 4 quarters.
Boothbay Fund Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $318K in Q2 2021.
23 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.